These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 3071777)
1. [Changes in the immunologic profile of newly-diagnosed diabetic patients during the first year of the disease]. Pizzul MG; Betterle C; De Campo C; Tonini G; Marinoni S; Pocecco M Pediatr Med Chir; 1988; 10(5):481-5. PubMed ID: 3071777 [TBL] [Abstract][Full Text] [Related]
2. [Detection of antibodies against pancreatic islet cells in clinical practice]. Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715 [TBL] [Abstract][Full Text] [Related]
4. [Cytoplasmic islet-cell antibodies (ICA) and cytoplasmic complement- fixing antibodies (CF-ICA) in patients with newly detected and short-lasting diabetes mellitus type 1]. Majkowska L; Czekalski S; Skwira J Pol Tyg Lek; 1990 May 7-14; 45(19-20):384-8. PubMed ID: 2255656 [TBL] [Abstract][Full Text] [Related]
5. Circulating immune complexes, insulin antibodies, and deposits of immunoglobulins in the skin in diabetes. Josephsen PG; Permin H; Juhl F; Enk B; Svehag SE Dan Med Bull; 1986 Jun; 33(3):171-4. PubMed ID: 3720367 [TBL] [Abstract][Full Text] [Related]
6. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin]. Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176 [TBL] [Abstract][Full Text] [Related]
7. Islet cell antibodies, circulating immune complexes and antinuclear antibodies in diabetes mellitus. Helmke K; Otten A; Mäser E; Wolf H; Federlin K Horm Metab Res; 1987 Jul; 19(7):312-5. PubMed ID: 3305275 [TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic islet cell antibodies in type I diabetics in Israel and their first-degree relatives. Assa S; Karp M; Erster B; Laron Z Isr J Med Sci; 1985 Sep; 21(9):727-30. PubMed ID: 3902719 [TBL] [Abstract][Full Text] [Related]
9. Characterization of islet cell antibody in insulin dependent diabetes: evidence for IgG1 subclass restriction and polyclonality. Millward A; Hussain MJ; Peakman M; Pyke DA; Leslie RD; Vergani D Clin Exp Immunol; 1988 Feb; 71(2):353-6. PubMed ID: 3127094 [TBL] [Abstract][Full Text] [Related]
10. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children. Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086 [TBL] [Abstract][Full Text] [Related]
12. [Immunologic parameters in insulin-dependent diabetes mellitus in children]. Strnová J; Páleníková O; Horváthová J; Getlík A Cesk Pediatr; 1990 Jan; 45(1):16-7. PubMed ID: 2203546 [TBL] [Abstract][Full Text] [Related]
13. [Variations in indicators of humoral immunity in type I diabetes]. Hulinský I; Dryáková M; Kaslík J; Malý J Vnitr Lek; 1990 Feb; 36(2):147-53. PubMed ID: 2186571 [TBL] [Abstract][Full Text] [Related]
14. Is immunity in diabetic patients influencing the susceptibility to infections? Immunoglobulins, complement and phagocytic function in children and adolescents with type 1 diabetes mellitus. Liberatore RR; Barbosa SF; Alkimin Md; Bellinati-Pires R; Florido MP; Isaac L; Kirschfink M; Grumach AS Pediatr Diabetes; 2005 Dec; 6(4):206-12. PubMed ID: 16390389 [TBL] [Abstract][Full Text] [Related]
15. Complement activation in diabetes mellitus. Bergamaschini L; Gardinali M; Poli M; Lorini R; Bosi E; Agostoni A J Clin Lab Immunol; 1991 Jul; 35(3):121-7. PubMed ID: 1688167 [TBL] [Abstract][Full Text] [Related]
16. Multiple antibody status in type 1 diabetic patients and subjects at various risk with islet-cell antibodies. Maugendre D; Chaillous L; Rohmer V; Lecomte P; Marechaud R; Saï P; Marre M; Charbonnel B; Allannic H; Delamaire M Diabetes Metab; 1997 Sep; 23(4):320-6. PubMed ID: 9342546 [TBL] [Abstract][Full Text] [Related]
17. Humoral immune abnormalities in human brucellosis. Gotuzzo E; Bocanegra TS; Alarcón GS; Carrillo C; Espinoza LR Allergol Immunopathol (Madr); 1985; 13(5):417-24. PubMed ID: 4083235 [TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the immune system in Down's syndrome patients]. Rascón Trincado MV; Lorente Toledano F; Muriel Ramos MM; Romo Cortina A; Salazar Villalobos V Allergol Immunopathol (Madr); 1984; 12(1):45-52. PubMed ID: 6233858 [TBL] [Abstract][Full Text] [Related]
19. Immunologic and genetic markers in insulin-dependent diabetes mellitus (type 1) in an Argentine population. Krochik AG; Mazza CS; Valdez SN; Stumpo RR; Papouchado ML; Iacono RF; Cardoso Landaburu AC; Sica MP; Ozuna B; Poskus E Medicina (B Aires); 2001; 61(3):279-83. PubMed ID: 11474874 [TBL] [Abstract][Full Text] [Related]
20. Negative correlation between ICA persistence and beta cell restoration after IDDM diagnosis. Manna R; Salvatore M; Scuderi F; Papa G; Marietti G; Greco AV; Ghirlanda G; Gambassi G Diabetes Res; 1988 Nov; 9(3):101-3. PubMed ID: 3072142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]